ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study

ABSTRACT Purpose Systemic treatment options for vulvar squamous cell carcinoma (VSCC) are limited. ROS1, a tyrosine kinase implicated, for example, in non‐small cell lung cancer (NSCLC), has recently shown responsiveness to tyrosine kinase inhibitors. This study investigated immunohistochemical ROS1...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Meletios P. Nigdelis, Annick Bitterlich, Mariam Parvanta, Bashar Haj Hamoud, Erich Franz Solomayer, Martin Ertz, Laura Schnöder, Annette Hasenburg, Bernd Holleczek, Mathias Wagner, Gilbert Georg Klamminger
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2025-08-01
Cyfres:	Cancer Medicine
Pynciau:	immunohistochemistry ROS1 tyrosine kinase inhibitors vulvar cancer
Mynediad Ar-lein:	https://doi.org/10.1002/cam4.71160
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!